rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
5
|
pubmed:dateCreated |
1997-8-4
|
pubmed:abstractText |
Gastro-oesophageal reflux disease may be treated with a drug forming a floating neutral raft in the stomach. The pectin-based raft-forming anti-reflux agent Aflurax (Idoflux) was examined, first regarding reduction of oesophageal acid exposure, and next as to its efficacy as maintenance treatment in patients with healed oesophagitis.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0954-691X
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
9
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
509-14
|
pubmed:dateRevised |
2009-10-16
|
pubmed:meshHeading |
pubmed-meshheading:9187886-Aged,
pubmed-meshheading:9187886-Anti-Ulcer Agents,
pubmed-meshheading:9187886-Antidiarrheals,
pubmed-meshheading:9187886-Cross-Over Studies,
pubmed-meshheading:9187886-Double-Blind Method,
pubmed-meshheading:9187886-Endoscopy, Digestive System,
pubmed-meshheading:9187886-Esophagitis,
pubmed-meshheading:9187886-Female,
pubmed-meshheading:9187886-Follow-Up Studies,
pubmed-meshheading:9187886-Gastric Acid,
pubmed-meshheading:9187886-Gastroesophageal Reflux,
pubmed-meshheading:9187886-Heartburn,
pubmed-meshheading:9187886-Humans,
pubmed-meshheading:9187886-Hydrogen-Ion Concentration,
pubmed-meshheading:9187886-Male,
pubmed-meshheading:9187886-Middle Aged,
pubmed-meshheading:9187886-Omeprazole,
pubmed-meshheading:9187886-Pectins,
pubmed-meshheading:9187886-Recurrence,
pubmed-meshheading:9187886-Safety,
pubmed-meshheading:9187886-Treatment Outcome
|
pubmed:year |
1997
|
pubmed:articleTitle |
Efficacy of a pectin-based anti-reflux agent on acid reflux and recurrence of symptoms and oesophagitis in gastro-oesophageal reflux disease.
|
pubmed:affiliation |
Department of Medical Gastroenterology, Odense University Hospital, Denmark.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|